Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jehad Charo
Observed names:
Charo, Jehad,
J Charo,
J. Charo
Institution:
F. Hoffmann-La Roche AG
Observed institutions:
F. Hoffmann-La Roche AG,
National Institutes of Health,
Karolinska University Hospital,
Max Delbrück Center,
Karolinska Institutet,
National Cancer Institute
show all 6
ORCID:
0000-0002-5409-9160
Observed ORCID:
0000-0002-5409-9160
OpenAlex ID:
A5079916764
The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations
2000
·
Birgitta Agerberth
, Jehad Charo
, et al.
·
Blood
·
870
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
2008
·
Anna Kruschinski
, Andreas Moosmann
, et al.
·
Proceedings of the National Academy of Sciences
·
213
Targeting of Human Dendritic Cells by Autologous NK Cells
1999
·
Julia L Wilson
, Lena C Heffler
, et al.
·
The Journal of Immunology
·
207
Identification of New HER2/ neu- Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas
1999
·
Yang Rongcun
, Flavio Salazar-Onfray
, et al.
·
The Journal of Immunology
·
195
Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines
2003
·
Aniruddha Choudhury
, Jehad Charo
, et al.
·
International Journal of Cancer
·
150
PDF
Bcl-2 Overexpression Enhances Tumor-Specific T-Cell Survival
2005
·
Jehad Charo
, Steven E. Finkelstein
, et al.
·
Cancer Research
·
145
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy
2021
·
Inja Waldhauer
, Valeria Gonzalez-Nicolini
, et al.
·
mAbs
·
134
PDF
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial
2010
·
Håkan Norell
, Isabel Poschke
, et al.
·
Journal of Translational Medicine
·
133
PDF
Constitutive IL-10 Production Accounts for the High NK Sensitivity, Low MHC Class I Expression, and Poor Transporter Associated with Antigen Processing (TAP)-1/2 Function in the Prototype NK Target YAC-1
1998
·
Max Petersson
, Jehad Charo
, et al.
·
The Journal of Immunology
·
122
NK Cell Triggering by the Human Costimulatory Molecules CD80 and CD86
1999
·
Julia L Wilson
, Jehad Charo
, et al.
·
The Journal of Immunology
·
115
PDF
Designer T cells by T cell receptor replacement
2006
·
Daniel Sommermeyer
, Julia Neudorfer
, et al.
·
European Journal of Immunology
·
111
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer
2008
·
Elisa Kieback
, Jehad Charo
, et al.
·
Proceedings of the National Academy of Sciences
·
107
A Synthetic Peptide Homologous to Functional Domain of Human IL-10 Down-Regulates Expression of MHC Class I and Transporter Associated with Antigen Processing 1/2 in Human Melanoma Cells
2004
·
Mónica Kurte
, Mercedes López
, et al.
·
The Journal of Immunology
·
105
PDF
Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes
1998
·
Koji Kono
, Yang Rongcun
, et al.
·
International Journal of Cancer
·
97
Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFNγ
2014
·
Ana Textor
, Joanna J. Listopad
, et al.
·
Cancer Research
·
96
PDF
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10
1997
·
F Salazar-Onfray
, J Charo
, et al.
·
The Journal of Immunology
·
92
Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy
2018
·
Benjamin Ribba
, Christophe Boetsch
, et al.
·
Clinical Cancer Research
·
80
Laminin-8 (α4β1γ1) is synthesized by lymphoid cells, promotes lymphocyte migration and costimulates T cell proliferation
2001
·
Tarekegn Geberhiwot
, Daniel Assefa
, et al.
·
Journal of Cell Science
·
72
Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies
2017
·
Ryan J. Hartmaier
, Jehad Charo
, et al.
·
Genome Medicine
·
61
PDF
HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice
2008
·
Simona Vertuani
, Chiara Triulzi
, et al.
·
Cancer Immunology Immunotherapy
·
61
PDF
Induction of PSA‐specific CTLs and anti‐tumor immunity by a genetic prostate cancer vaccine
2004
·
Anna‐Karin Roos
, Maxim Pavlenko
, et al.
·
The Prostate
·
55
Protective Efficacy of a DNA Influenza Virus Vaccine Is Markedly Increased by the Coadministration of a Schiff Base-Forming Drug
2004
·
Jehad Charo
, Jan Alvar Lindencrona
, et al.
·
Journal of Virology
·
52
Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies
2024
·
Sebastian Dziadek
, Anton Kraxner
, et al.
·
Frontiers in Immunology
·
50
PDF
Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data
2023
·
WeiQing Venus So
, David Dejardin
, et al.
·
Journal for ImmunoTherapy of Cancer
·
50
PDF
Oncogene-Targeting T Cells Reject Large Tumors while Oncogene Inactivation Selects Escape Variants in Mouse Models of Cancer
2011
·
Kathleen Anders
, Christian Buschow
, et al.
·
Cancer Cell
·
48
PDF
Show more works
View as search
Works count:
170
Citation count:
3,993
H-index:
30
I10-index:
48
Year
Topic
Type